Clinical impacts of sacubitril/valsartan on patients eligible for cardiac resynchronization therapy.

Hsin-Ti Huang,Jin-Long Huang,Po-Lin Lin,Ying-Hsiang Lee,Chien-Yi Hsu,Fa-Po Chung,Chia-Te Liao,Wei-Ru Chiou,Wen-Yu Lin,Huai-Wen Liang,Hung-Yu Chang

ESC heart failure（2022）

引用 7|浏览7

暂无评分

摘要

Despite SAC/VAL treatment, wide QRS durations are associated with lower degrees of left ventricular improvement than narrow ones in the HFrEF patients. Optimal intervention timing for the CRT-eligible patients requires further investigation.

查看译文

关键词

Cardiac resynchronization therapy,Guideline directed medical therapy,Heart failure,Left bundle branch block,Reverse cardiac remodelling,Sacubitril/valsartan

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要